Skip to main content
Premium Trial:

Request an Annual Quote

Frank Jellinek Jr., Robert Friel, succeeds Peter Coggins, Aaron Geist, Nathan Collins, Scienion, Open Biosystems, Qiagen

Premium

Migrations

Frank Jellinek Jr., chairman emeritus of Fisher Scientific International, died Tuesday morning in a plane crash at the McClellan-Palomar Airport in Carlsbad, Calif.

Jellinek was 60 years old. He is survived by his wife, two children, and two grandchildren.

Jellinek was a veteran in the scientific-research industry with more than 40 years of experience. He was appointed chairman emeritus following the 2004 merger of Apogent Technologies and Fisher Scientific International.


PerkinElmer this week appointed Robert Friel as president of the Life and Analytical Sciences division. He succeeds Peter Coggins, who will retire in February, but will continue to support the company as a senior advisor and consultant through mid-2007.

Prior to his appointment, Friel served as executive vice president and chief financial officer of PerkinElmer. He will continue in the role of vice chairman, and remain a member of its board of directors. Prior to joining PerkinElmer, Friel held several senior management positions at AlliedSignal, now Honeywell International. Friel also serves on the boards of Millennium Pharmaceuticals and Fairchild Semiconductor.

Separately, PerkinElmer appointed Aaron Geist vice president of business development.

Geist was formerly director and senior research analyst at Robert W. Baird. He has a PhD in microbiology and molecular virology from Thomas Jefferson University in Philadelphia and BS degrees in genetics and biology from the University of Western Ontario.


SRI International this week announced that Nathan Collins has joined the institute as executive director of the biosciences division.

Collins previously was employed by San Diego-based Discovery Partners International, most recently as a corporate vice president. He holds a PhD in chemistry and a BS in chemistry and mathematics from the University of Southampton, UK, and a postdoc from the University of Arizona.

 

Products

Scienion this week announced the availability of the sciFLEXARRAYER, an ultra-low-level liquid-handling system for miniaturized cell-based assays.

According to Scienion, sciFLEXARRAYER allows the aspiration of single cells or low amounts of cells for a variety of cell-based assays in the fields of functional genomics and drug development. The instrument allows researchers to perform multiple cell-based assays in nanoliter drops, thereby increasing assay speed and reducing costs, Scienion said.


Open Biosystems announced this week the availability of its lentiviral microRNA-adapted shRNA library.

The library offers coverage for greater than 5,000 transcripts. Complete genome coverage is expected by mid-2006, the company said.


Qiagen has introduced the human validated kinase siRNA set version 1.0.

According to the company, the set is provided in 100-pmol, 0.25-nmol, or 1-nmol scales. Subsets for tyrosine kinases and serine/threonine kinases are also available.

Qiagen also released the whole human genome siRNA set version 1.0. This set contains siRNAs targeting more than 22,000 human genes.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more